Publication Date
2020
Document Type
Book
Description
2.6 million Americans have opioid use disorder (OUD), but only 10.6% have received treatment, mainly because there are not enough buprenorphine waivered providers, especially in rural areas. There is a need to address attitudes and barriers of why primary care providers are reluctant to get buprenorphine waivers. A recent study reported that only 28.6% of family medicine residencies have a required addiction medicine curriculum and only 31.2% had at least one graduate obtain a waiver to prescribe buprenorphine in the past year. Promoting buprenorphine treatment through training and education increases the number of buprenorphine providers. An educational program was presented to health care providers in rural upstate New York. The goal of this presentation was to improve provider knowledge about the need for buprenorphine waivered providers in the rural primary care setting. A pretest and posttest were given to measure attitudes and barriers before and after the presentation. There was significance found between pretest and posttest attitude scores. (p=0.001) Providers that had buprenorphine training in residency or took a buprenorphine class, were more likely to have their buprenorphine license (p=0.001). This presentation improved provider attitudes in treating patients with OUD with buprenorphine. Education increases discussion and it is recommended that medical professionals who already have their buprenorphine licenses, facilitate this presentation to fellow providers in an effort to educate and mentor them.
Files
Download Full Text (882 KB)
Recommended Citation
Schultz, Julia, "Acceptance of Primary Care Providers Acquiring Buprenorphine Waivers for Opiod Use Disorder Population in Rural Upstate New York" (2020). Research Days Posters Spring 2020. 81.
https://orb.binghamton.edu/research_days_posters_spring2020/81